More than 70% of UK public endorses human gene editing to treat disease

featured art marinamuun

Scientists have been given a green light from members of the public to press ahead with developing gene editing therapies for life-threatening conditions. People are also broadly in favour of using the powerful technology to stamp out inherited diseases, according to the results of a Royal Society survey.

“People have told us that they are cautiously optimistic about the potential of the new methods for research and applications, but they are understandably concerned about the risks, and the ethical and social implications.” [said professor Robin Lovell-Badge]

“Working out what we as a society find ethically acceptable requires open and inclusive debate involving many voices – and any decisions as to their use should not be left to scientists and clinicians alone, but involve all sectors of society.”

Of the survey participants, 83% believed using gene editing to conquer incurable devastating disorders such as muscular dystrophy would be positive for society.

Almost the same proportion, 82%, had no qualms about the technology being brought to bear on conditions such as leukaemia for which other treatments are already available. Nearly three quarters (73%) were happy for gene editing to be used to treat arthritis and other non-life threatening conditions.

A total of 69% drew the line at cosmetic gene alterations affecting appearance, while 60% felt the same about editing higher intelligence or other abilities such as athletic prowess into people’s DNA.

Read full, original post: Members of the public `cautiously optimistic´ about gene editing

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

ChatGPT Image May 10, 2026, 08_16_59 PM 2
Overmedicalization? RFK Jr.’s antidepressant crackdown raises conflict questions over his fee stake in Wisner Baum, the tort firm built on suing drug makers
Picture1-5
Science Disinformation Gap: The transatlantic battle over social media and censorship
Screenshot-2026-05-08-at-3.40.33-PM
Seeds of power: China turns to genetic engineering to become global superpower
Picture1-14
When superbugs threaten vulnerable children: Can AI help solve antibiotic resistance?
ChatGPT-Image-Apr-13-2026-02_20_22-PM
Viewpoint: Misinformation infodemic? Why assessing evidence is so challenging 
S
As vaccine rejectionism spreads, measles may be taking a more dangerous turn
Screenshot-2026-05-01-at-1.29.41-PM
Viewpoint: What happens when whole grains meet modern food manufacturing? Labels don’t tell the whole story.
Screenshot 2026-05-08 at 3.01
Transforming farming and nutrition with AI and robotics? Larry Ellison’s half-billion-dollar Hawaii greenhouse dream goes bust
Farmers can talk to plants
Farmers are a major source of misinformation—about farming
ChatGPT-Image-May-8-2026-01_41_33-PM-3
Viewpoint: Surge of climate misinformation traced to right wing and anti-wind activists 
Screenshot-2026-04-20-at-2.26.27-PM
Viewpoint — Food-fear world: The latest activist scientists campaign: Cancer-causing additives
Screenshot-2026-03-13-at-12.14.04-PM
The FDA wants to make many popular prescription drugs OTC—a great idea. Here’s why it’s unlikely to happen
ChatGPT-Image-Mar-27-2026-11_47_30-AM-2
FDA’s expedited drug reviews are hailed in some quarters but other approval practices are problematic
Screenshot-2026-04-12-135256
Bixonimania: The fake disease scam that AI swallowed whole

Sorry. No data so far.

glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.